JP2006500930A5 - - Google Patents

Download PDF

Info

Publication number
JP2006500930A5
JP2006500930A5 JP2004539048A JP2004539048A JP2006500930A5 JP 2006500930 A5 JP2006500930 A5 JP 2006500930A5 JP 2004539048 A JP2004539048 A JP 2004539048A JP 2004539048 A JP2004539048 A JP 2004539048A JP 2006500930 A5 JP2006500930 A5 JP 2006500930A5
Authority
JP
Japan
Prior art keywords
gene
cholesterol
haplotype
patients
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004539048A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006500930A (ja
JP4575775B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2003/010798 external-priority patent/WO2004029618A2/en
Publication of JP2006500930A publication Critical patent/JP2006500930A/ja
Publication of JP2006500930A5 publication Critical patent/JP2006500930A5/ja
Application granted granted Critical
Publication of JP4575775B2 publication Critical patent/JP4575775B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004539048A 2002-09-30 2003-09-29 免疫抑制療法に際してのコレステロール上昇予知方法 Expired - Fee Related JP4575775B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41512302P 2002-09-30 2002-09-30
PCT/EP2003/010798 WO2004029618A2 (en) 2002-09-30 2003-09-29 Methods to predict cholesterol elevations during immunosuppressant therapy

Publications (3)

Publication Number Publication Date
JP2006500930A JP2006500930A (ja) 2006-01-12
JP2006500930A5 true JP2006500930A5 (https=) 2006-11-16
JP4575775B2 JP4575775B2 (ja) 2010-11-04

Family

ID=32043422

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004539048A Expired - Fee Related JP4575775B2 (ja) 2002-09-30 2003-09-29 免疫抑制療法に際してのコレステロール上昇予知方法

Country Status (13)

Country Link
US (2) US7732134B2 (https=)
EP (1) EP1549770B1 (https=)
JP (1) JP4575775B2 (https=)
CN (1) CN100453650C (https=)
AT (1) ATE389034T1 (https=)
AU (1) AU2003287955B2 (https=)
BR (1) BR0314552A (https=)
CA (1) CA2500979A1 (https=)
DE (1) DE60319719T2 (https=)
ES (1) ES2302959T3 (https=)
IL (1) IL167639A (https=)
PT (1) PT1549770E (https=)
WO (1) WO2004029618A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0611021A2 (pt) * 2005-05-31 2010-08-10 Novartis Ag combinação de inibidores de hmg-coa redutase e inibidores de mtor
HUE052213T2 (hu) 2009-11-06 2021-04-28 Univ Leland Stanford Junior Grafitkilökõdés nem invazív diagnosztizálása szervátültetett betegekben
KR101924162B1 (ko) * 2010-03-15 2018-11-30 버지니아 커먼웰스 유니버시티 기도의 염증 및 이상성 점액섬모 전달의 치료법으로서의 에어로졸화 댑손
US20130203769A1 (en) * 2012-02-08 2013-08-08 University Of Cincinnati Targeting Metabolic Adaptive Responses to Chemotherapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686246A (en) 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
US5698399A (en) * 1996-04-05 1997-12-16 Duff; Gordon W. Detecting genetic predisposition for osteoporosis
US6210877B1 (en) * 1997-03-10 2001-04-03 Interleukin Genetics, Inc. Prediction of coronary artery disease
US6524795B1 (en) 1997-03-10 2003-02-25 Interleukin Genetics, Inc. Diagnostics for cardiovascular disorders
GB9711040D0 (en) * 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease
CN1753903B (zh) * 2001-11-19 2010-05-12 白介素遗传公司 影响转录和对炎性和传染性疾病的敏感性的白细胞介素-1基因座的功能多态性

Similar Documents

Publication Publication Date Title
JP5701216B2 (ja) 加齢黄斑変性における遺伝的多型
US20040096874A1 (en) Characterization of CYP 2D6 genotypes
AU2017318669B2 (en) Methods and composition for the prediction of the activity of enzastaurin
JP5676623B2 (ja) 加齢黄斑変性における遺伝的多型性
Ingelsson et al. Genotyping of apolipoprotein E: comparative evaluation of different protocols
EP2619308A2 (en) Genes linking several complications of type-2 diabetes (t2d)
US20180230541A1 (en) Method for predicting the onset of extrapyramidal symptoms (eps) induced by an antipsychotic-based treatment
AU2005208566A1 (en) APOE genetic markers associated with age of onset of Alzheimer's Disease
JP2006500930A5 (https=)
WO2007144874A1 (en) Rgs2 genotypes associated with extrapyramidal symptoms induced by antipsychotic medication
US20100184798A1 (en) Methods to Predict Cholesterol Elevations during Immunosuppressant Therapy
US20050255498A1 (en) APOC1 genetic markers associated with age of onset of Alzheimer's Disease
US20050250122A1 (en) APOA4 genetic markers associated with progression of Alzheimer's disease
WO2005042762A2 (en) Lrpap1 genetic markers associated with galantamine response
WO2005059104A2 (en) Slc5a7 genetic markers associated with age of onset of alzheimer's disease
CA2441353A1 (en) Single nucleotide polymorphisms diagnostic for schizophrenia
MXPA06003827A (es) Uso de polimorfismos geneticos para predecir hepatotoxicidad inducida por farmaco.
JP4549297B2 (ja) パクリタキセル療法による副作用を予測する方法およびキット
US20120289593A1 (en) Methods for risk assessment, treating, and diagnosing myocardial infarction
US8080374B2 (en) Methods of diagnosing cardiovascular disease
WO2007038155A2 (en) Methods of diagnosing cardiovascular disease
Broeckel et al. Single-Nucleotide Polymorphisms: Testing DNA Variation for Disease Association
Tate Clinical applications of pharmacogenetics
HK1084445B (en) Methods to predict cholesterol elevations during immunosuppressant therapy
HK1173751B (en) Genetic polymorphisms in age-related macular degeneration